Concepedia

Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1α-hydroxyvitamin D2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison

Hla M. Maung, Loganathan Elangovan, João Frazão, John D. Bower, Bobby J. Kelley, Sergio R. Acchiardo, Hector J. Rodriguez, Keith C. Norris, Jerald F. Sigala, Mark Rutkowski,

American Journal of Kidney Diseases · 2001 · 23 citations · 17 references

References

17

The spectrum of bone disease in end-stage renal failure—An evolving disorder

Donald J. Sherrard, Gavril Hercz, York Pei et al. · Kidney International · 1993 · 737 citations

Medicine, Nephrology, Bone Metabolism +15

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Eduardo Slatopolsky, Carol Weerts, J Thielan et al. · Journal of Clinical Investigation · 1984 · 686 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure.

Bruce W. Hollis · Clinical Chemistry · 1986 · 303 citations

Medicine, Biochemistry, Bioavailability +15

Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD

L. Darryl Quarles, Daniel A. Yohay, Barbara A. Carroll et al. · Kidney International · 1994 · 252 citations

Medicine, Endocrinology, Nephrology +10

Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia

L. D. Quarles · The Journal of Clinical Endocrinology & Metabolism · 1992 · 199 citations

Medicine, Endocrinology, Nephrology +13